Anti-immunoglobulin E in the treatment of refractory atopic dermatitis. - Wikidata - awgldk - TriplyDB

Anti-immunoglobulin E in the treatment of refractory atopic dermatitis.

Anti-immunoglobulin E in the treatment of refractory atopic dermatitis.

http://www.wikidata.org/entity/Q34307177

about

Advances in understanding and managing atopic dermatitis Biological Treatments in Atopic Dermatitis Consensus Guidelines for the Treatment of Atopic Dermatitis in Korea (Part II): Systemic Treatment.Retrospective analysis of the efficacy of omalizumab in chronic refractory urticaria Systemic Treatment of Adult Atopic Dermatitis: A Review.Intrinsic atopic dermatitis shows similar TH2 and higher TH17 immune activation compared with extrinsic atopic dermatitis.Novel investigational therapies for atopic dermatitis.Treatment of Eczema: Corticosteroids and Beyond.Off-Label Uses of Omalizumab.New and Emerging Targeted Systemic Therapies: A New Era for Atopic Dermatitis.Systemic Agents for Severe Atopic Dermatitis in Children.Advances in therapeutic strategies for the treatment of pruritus.Effects of Allergic Sensitization on Antiviral Immunity: Allergen, Virus, and Host Cell Mechanisms.Omalizumab for atopic dermatitis: case series and a systematic review of the literature.Immunologic Targets in Atopic Dermatitis and Emerging Therapies: An Update.Novel Therapeutic Approaches to Atopic Dermatitis.Are Biologics Efficacious in Atopic Dermatitis? A Systematic Review and Meta-Analysis.

P2860

Q26766224-91850F57-7109-4D05-A77F-7B3017F1F4FA Q26799579-7D3E9CCC-8770-4DF3-9ED8-58330EC3C6B9 Q36214254-3B47CB5C-A30E-4AA7-AAFD-6FAB769A0B85 Q37121967-26581239-12E4-4152-903E-9B5F5854107F Q37679948-FA28150D-9AD2-48D0-BC02-1C0D4B573539 Q37709674-6738CB8D-B359-4285-BB0E-566088390311 Q38247119-D51A5EDF-0BB4-45FC-B52A-82BD9E602797 Q38419338-6FEC0CD7-A033-4504-BA1E-7DA582A789CD Q38517653-D5DE2553-08FD-4CCB-9473-AE96CD6AB5EB Q38602326-709D4B96-D24E-4C24-A19A-DE99127382DC Q38627693-2B3CE49D-B0EC-4B52-A1DF-63ABEC9DE8FA Q38656850-04DF6B5F-DBC6-4FBE-A3EB-F58BD0D595BD Q38753828-7140AF27-908D-453E-AD4B-562BA789CFC6 Q38874440-5AFB00D9-2AA1-4CEA-BE2A-20A678A79989 Q38883893-C6A92828-09F0-4900-AAF2-DA63F08322C7 Q47569916-C9971390-CEF5-4BDD-BC7C-1FDE3599E047 Q47664702-269E3A23-3D68-429F-A83D-BE2C8C774EE4

P2860

Anti-immunoglobulin E in the treatment of refractory atopic dermatitis.

http://www.wikidata.org/entity/Q34307177

description

2012 nî lūn-bûn

@nan

2012 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2012 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

name

Anti-immunoglobulin E in the treatment of refractory atopic dermatitis.

@ast

Anti-immunoglobulin E in the treatment of refractory atopic dermatitis.

@en

Anti-immunoglobulin E in the treatment of refractory atopic dermatitis.

@nl

type

label

Anti-immunoglobulin E in the treatment of refractory atopic dermatitis.

@ast

Anti-immunoglobulin E in the treatment of refractory atopic dermatitis.

@en

Anti-immunoglobulin E in the treatment of refractory atopic dermatitis.

@nl

prefLabel

Anti-immunoglobulin E in the treatment of refractory atopic dermatitis.

@ast

Anti-immunoglobulin E in the treatment of refractory atopic dermatitis.

@en

Anti-immunoglobulin E in the treatment of refractory atopic dermatitis.

@nl

P1433

Q34307177-12D9A536-FF7F-452C-8B9A-486757C89926

P1476

Q34307177-F03972F8-5D9D-46A8-885E-4C47FBC4F536

P2093

Q34307177-3B1096E8-6B5E-4BA9-B884-49F0D92522F1

Q34307177-439144E7-10FB-4905-86E3-2D73D7BFA06E

Q34307177-910B09FA-A059-4E41-9794-CDC952B56FE5

Q34307177-C2D1C61D-00FD-4D33-8746-C2C96F030D69

Q34307177-EF1EA2F9-0804-43BE-B823-FC55C085AB70

P2860

Q34307177-2F3174A4-90FC-469B-8B64-3433B222F186

Q34307177-537416A0-813F-4C9D-A5C2-0CA998ABDFB9

Q34307177-B3C300D6-95D5-419B-9EB9-17366CD8472B

P304

Q34307177-D1DCB93F-02EA-43F1-9766-DF516F3A686D

P31

Q34307177-60BFCC9A-F426-42D4-88C2-CF75E3182F22

P356

Q34307177-357A9085-D453-4E9C-B8DB-3870F4AA98B1

P433

Q34307177-5EBFC2F0-DA31-43F5-89D5-3B1EFE8E092E

P478

Q34307177-066AFAD3-E17E-4F66-B3B5-01459FFEAEDC

P577

Q34307177-34DD8ED9-BB36-4645-A09A-843257E27B94

P698

Q34307177-DBB3D2CC-8835-491F-9B46-D1D5C7E103CA

P356

J.1365-2230.2012.04438.X

P1433

Clinical and Experimental Dermatology

P1476

Anti-immunoglobulin E in the treatment of refractory atopic dermatitis.

@en

P2093

B J Kim

http://www.w3.org/2001/XMLSchema#string

D H Kim

http://www.w3.org/2001/XMLSchema#string

K Y Park

http://www.w3.org/2001/XMLSchema#string

M N Kim

http://www.w3.org/2001/XMLSchema#string

S K Mun

http://www.w3.org/2001/XMLSchema#string

P2860

10. Atopic dermatitis.

Diagnosis and treatment of atopic dermatitis in children and adults: European Academy of Allergology and Clinical Immunology/American Academy of Allergy, Asthma and Immunology/PRACTALL Consensus Report.

Relationship between omalizumab pharmacokinetics, IgE pharmacodynamics and symptoms in patients with severe persistent allergic (IgE-mediated) asthma.

P304

496-500

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/J.1365-2230.2012.04438.X

http://www.w3.org/2001/XMLSchema#string

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

38

http://www.w3.org/2001/XMLSchema#string

P577

2012-10-22T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23083013

http://www.w3.org/2001/XMLSchema#string